Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment118% Female48%% White61%
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMATPEP3001Data PartnerJohnson & JohnsonCondition StudiedPartial Seizure DisorderMean/Median Age (Years)1
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2021-4712 : Real time monitoring of individual response to antiseizure medication treatment during clinical trials
- 2020-4276 : Psychiatric Symptoms as Adverse Events of Topiramate Therapy: Systematic Review and Meta-Analysis
- 2016-1038 : Development and validation of historical control using placebo data from pediatric epilepsy studies